Cat eating from a bowl beside Kitty Up ResiliBiome probiotic box and sachets on a kitchen counter, with “70%” text overlay.

How the Gut and the Immune System Interact in Cats

Table of Contents
    At a Glance
    • The digestive tract is one of the body's largest immune interfaces. Gut-associated lymphoid tissue — tonsils, Peyer's patches, and diffuse lymphoid tissue distributed along the GI tract — sits directly behind the gut lining.
    • You will often see the claim that "70% of the immune system lives in the gut." That figure comes from general mammalian and human mucosal immunology. We have not found feline-specific research establishing that number in cats, so we don't state it as a cat fact.
    • What is well documented in cats: cats with chronic enteropathies show measurably different gut bacterial communities than healthy cats. The gut–immune relationship is real and observable in this species.
    • Yeast beta-glucans are recognized by immune receptors including Dectin-1. That mechanism is well described across mammals. Published feline outcome data are limited, and not every feline study has shown the expected effect.
    • Feline-origin probiotic strains are a sound formulation rationale — strains isolated from cats tend to handle feline gut conditions well — but origin alone is not proof of clinical benefit. Probiotic effects are strain-specific.
    • ResiliBiome™ is built as a probiotic + prebiotic + postbiotic system: 5 billion CFU across five strains (three of them feline-origin), 120 mg FOS, 70 mg MOS, 34 mg 1,3/1,6 yeast beta-glucans, and 100 mg heat-treated Lactobacillus fermentate.

    THE FELINE GUT HEALTH SERIES — This is the fourth article in our September series on the feline gut. We started with what the cat gut microbiome actually is and what disrupts it, looked at the hidden toll of antibiotics, and reviewed what the evidence really shows about diarrhea and probiotics. Here we look at the connection between the gut and the immune system — including where the popular version of that story outruns the research.

    The gut is an immune organ, not just a digestive one

    Your cat's intestinal lining is a single layer of cells separating the inside of the body from an enormous, constantly changing population of bacteria, food particles, and anything else that arrives by mouth. It has to let nutrients through while keeping most of the rest out — and it has to decide, thousands of times a day, what is harmless and what is not.

    That decision-making doesn't happen in the abstract. It happens in tissue. Gut-associated lymphoid tissue — tonsils, Peyer's patches, and diffuse lymphoid tissue distributed along the GI tract — sits directly beneath and within the gut lining. Peyer's patches are the induction sites: specialized M cells sample material from the gut lumen, dendritic cells present it, T cells respond, and B cells class-switch to produce immunoglobulin A, the antibody that coats mucosal surfaces.

    This is why gut health and immune function are discussed together. It isn't a marketing metaphor. It's anatomy.

    Where we part company with the usual claim. The line you'll see repeated everywhere — including, we'll note, on plenty of pet supplement labels — is that "70% of the immune system is in the gut." That figure traces back to human and general mammalian mucosal immunology. We have not been able to find a feline-specific study that establishes it in cats. So we don't say it. The gut being a major immune interface in cats is well supported. A specific percentage in cats is not.

    What the microbiome actually does for immune signaling

    The bacteria living in the gut aren't passive tenants. They ferment fiber into short-chain fatty acids, transform bile acids, and metabolize tryptophan — and those metabolites are among the main signals that shape inflammation and cell turnover in the intestinal lining. The microbes talk to the immune system chemically, and the immune system adjusts.

    In cats, this relationship shows up most clearly when it goes wrong. Research using a feline dysbiosis index found that roughly three-quarters of cats with chronic enteropathy have an altered fecal microbiota, with patterns resembling those seen in human inflammatory bowel disease. Studies of feline chronic enteropathy consistently report reduced bacterial diversity, lower abundance of beneficial taxa such as Bifidobacterium and members of the Ruminococcaceae, and higher abundance of Enterobacteriaceae. Altered microbial tryptophan metabolism has been documented in cats with chronic inflammatory enteropathy and low-grade intestinal T-cell lymphoma.

    Here is the honest framing: these are associations observed in cats with disease. They establish that gut microbial composition and intestinal immune status travel together in cats. They do not establish that changing the microbiome of a healthy cat changes that cat's immune outcomes. Those are different questions, and only the first one is settled. We wrote more about what disrupts the feline microbiome in the first article in this series.

    Beta-glucans: a well-described mechanism, and an honest look at the feline evidence

    Beta-glucans are polysaccharides from yeast and fungal cell walls. Their interaction with the mammalian immune system is one of the better-characterized stories in nutritional immunology: they are recognized by pattern-recognition receptors on innate immune cells, principally Dectin-1 and complement receptor 3, which is how a non-infectious dietary compound can register as a signal at all.

    The language you'll usually see next is that beta-glucans "prime the immune system without triggering inflammation." That's tidier than the evidence. What the mechanistic work supports is that beta-glucan recognition through these receptors can modulate innate immune cell responsiveness — the phenomenon sometimes described as trained innate immunity. Whether that translates into a measurable immune benefit in a healthy cat is a separate question, and the feline literature is thin.

    It is also not uniformly positive, and we'd rather say so. A controlled study of 35 cats given 1,3/1,6-beta-glucans around rabies vaccination measured antibody titers at days 0, 21, and 42. The non-supplemented group had higher post-vaccination titers than the supplemented group. Beta-glucan did not produce the expected effect in that model. A 2024 review of beta-glucan applications in dogs and cats reached a similar conclusion about the state of the field: the mechanistic rationale is strong, and species-specific clinical evidence is still being built.

    So when we include 34 mg of 1,3/1,6 yeast beta-glucans in ResiliBiome, we're being clear about what that is: a formulation choice grounded in well-established mammalian immunology, included because the gut is where innate immune cells encounter dietary compounds. It is not a claim that your cat's immune response will measurably improve, and it is certainly not a claim that it prevents illness.

    Why feline-origin strains — and what that does and doesn't prove

    Most probiotics sold for cats were originally isolated from humans, dairy, or other species. The rationale for using feline-origin strains is straightforward: bacteria isolated from the cat gut have already demonstrated they can survive feline gastric acid and bile, and adhere to feline intestinal tissue. Comparative work supports this — feline-origin isolates have shown superior bile tolerance relative to well-known human-derived reference strains, with comparable adhesion. A growing body of veterinary nutrition research now argues for host-specific probiotic selection as a design principle in companion animal foods.

    ResiliBiome uses three feline-origin strains: Limosilactobacillus reuteri KU-LR01, Lacticaseibacillus paracasei KU-LP01, and Pediococcus acidilactici KU-PA01. They are joined by Bifidobacterium animalis subsp. lactis and the beneficial yeast Saccharomyces boulardii.

    What feline origin does not establish is clinical superiority. A strain from a cat is more likely to survive the trip and stay put. That's a real and useful advantage. It is not evidence that the strain produces better health outcomes than a well-studied strain from another source, and we won't present it that way. Probiotic effects are strain-specific — which is exactly why strain IDs on the label matter.

    Secretory IgA: what the cat studies actually measured

    Secretory IgA is the antibody that coats mucosal surfaces, and it is the outcome most often reached for when someone wants to demonstrate that a probiotic "supports immunity." It's worth being precise about what has been shown in cats specifically, because this is a place where evidence from one species and one strain gets borrowed freely.

    A frequently cited 2007 feline trial of Enterococcus faecium SF68 — a bacterium, not a yeast, despite how it is often described — is often summarized as showing increased fecal IgA in cats. It did not. That study reported that total fecal IgA and IgG concentrations were similar between supplemented and control cats; its significant immune finding was a difference in circulating CD4+ lymphocyte percentage. The fecal IgA increase people associate with SF68 came from a separate trial in puppies. Different species, different endpoint.

    There is, however, real feline evidence. A randomized, blinded, controlled trial in healthy adult breeding cats supplemented with Saccharomyces cerevisiae var. boulardii DSM 34246 for 35 days found a significant increase in fecal IgA, alongside improvements in body condition and fecal parameters. That is a genuine feline result, in healthy cats, on an immune-relevant endpoint.

    The distinction we have to draw is unmistakable: that trial used a specific, named S. boulardii strain, DSM 34246. ResiliBiome contains S. boulardii, but a different strain. Strain-level differences in probiotics are real, and evidence does not transfer between strains. We're citing that study because it's the honest state of the feline literature — not because it's a result we can claim for our own formula.

    Building a More Complete Gut-Support System

    A gut-support formula shouldn't lean on a single ingredient, and the three categories in ResiliBiome do genuinely different jobs. Grouping them together as one undifferentiated blend obscures that, so here's what each part is actually for.

    • Probiotics — 5 billion CFU across five strains. Three feline-origin strains (L. reuteri KU-LR01, L. paracasei KU-LP01, P. acidilactici KU-PA01) plus B. animalis subsp. lactis and S. boulardii. Live organisms, selected for survival through the feline stomach and adhesion in the feline gut.
    • Prebiotics — two ingredients, two different mechanisms.
      Fructo-oligosaccharides (FOS), 120 mg. FOS is a fermentable substrate. Gut bacteria can actually eat it, and in feline feeding studies short-chain FOS has been associated with increased Bifidobacterium populations, higher production of short-chain fatty acids including butyrate, and lower fecal pH. This is the ingredient that fits the familiar "feeds the good bacteria" description.
      Mannan-oligosaccharides (MOS), 70 mg. MOS works differently, and describing it the same way as FOS would be inaccurate. MOS is only partially fermentable. Its primary documented mechanism is physical: many enteropathogenic bacteria attach to the gut wall using mannose-specific type-1 fimbriae, and MOS presents mannose residues that those fimbriae bind instead — so the bacteria are carried through rather than colonizing. Secondary effects reported in the literature include support for goblet cell activity and mucin production. It supports the gut environment; it isn't primarily bacterial food.
    • Postbiotic — 100 mg heat-treated Lactobacillus fermentate. Postbiotics are non-living microbial components and metabolites. They don't need to survive or colonize, because they aren't alive. Feline work in this area is early but encouraging: a 2025 study in healthy cats using a heat-inactivated Bifidobacterium animalis subsp. lactis postbiotic over 28 days reported reduced markers of intestinal permeability and shifts in immune signaling. Note that the postbiotic used there is a heat-inactivated Bifidobacterium, not the Lactobacillus fermentate in ResiliBiome — we include it as evidence that the postbiotic category is being taken seriously in cats, not as a result attributable to our ingredient.
    • Yeast beta-glucans — 34 mg, 1,3/1,6. Discussed above. A microbe-derived bioactive with a well-described mammalian recognition pathway and limited feline outcome data.

    A note on timelines

    You'll see confident week-by-week schedules for how a cat's gut "rebuilds" on a supplement. We don't publish one, because the underlying research doesn't support that level of precision, and individual cats vary enormously depending on diet, age, prior antibiotic exposure, and baseline microbiome.

    What we can say is practical: feeding trials in cats generally run four weeks or longer before measuring meaningful change, which is why our feeding guidance suggests using ResiliBiome for at least four to six weeks. For cats that are picky or sensitive, starting at half a sachet daily for three to five days makes the transition easier. If your cat has ongoing digestive signs, that's a conversation for your veterinarian — not a supplement question.

    The Kitty Up Takeaway

    The gut really is a major immune interface in cats — that part of the story holds up. What doesn't hold up is the tidy version: a specific percentage, a guaranteed immune boost, a fixed timeline. We'd rather give you the version that survives scrutiny.

    ResiliBiome is built on that principle. Feline-origin strains because they're better suited to the feline gut, not because origin proves efficacy. FOS and MOS because they do two different useful things, not because "prebiotic" sounds good. Beta-glucans because the mammalian immunology is sound, stated plainly as a formulation rationale. And a postbiotic because non-living microbial components don't have to survive the trip to matter.

    See what's in ResiliBiome™ — every strain, every amount

    Frequently asked questions

    Is most of a cat's immune system really in the gut?
    The gut is one of the body's largest immune interfaces, and gut-associated lymphoid tissue runs the length of the digestive tract. But the widely quoted "70%" figure comes from human and general mammalian mucosal immunology, and we haven't found feline-specific research establishing that number in cats. The qualitative point is well supported; the specific percentage isn't, for cats.

    How does gut health affect a cat's immune system?
    Gut bacteria produce metabolites — short-chain fatty acids, modified bile acids, tryptophan derivatives — that influence inflammation and cell turnover in the intestinal lining, where a large share of immune tissue sits. In cats, this link is clearest in disease: cats with chronic enteropathy show measurably different microbial communities than healthy cats.

    Can probiotics support immune health in cats?
    There is genuine feline evidence on immune-relevant markers — for example, a controlled trial of a specific S. boulardii strain in healthy adult cats found a significant increase in fecal IgA over 35 days. But results are strain-specific and don't transfer between strains, and a change in a marker is not the same as a change in whether a cat gets sick. Probiotics are not a treatment or a preventive for any disease.

    What are beta-glucans?
    Polysaccharides from yeast and fungal cell walls. Innate immune cells recognize them through receptors including Dectin-1, which is how a dietary compound can act as an immune signal. The mechanism is well described in mammals generally. Feline-specific outcome data are limited, and at least one controlled feline study did not find the expected effect.

    Does a feline-origin probiotic work better for cats?
    Feline-origin strains have a real practical advantage: they've already shown they can survive feline stomach acid and bile and adhere to feline intestinal tissue. Comparative studies support that. But origin alone does not demonstrate better health outcomes — that requires strain-specific evidence, and it should be evaluated strain by strain.

    What does dysbiosis mean?
    An imbalance in the gut microbial community — typically reduced diversity, fewer beneficial organisms, and more of the ones associated with inflammation. In cats it can be quantified with a validated feline dysbiosis index, and roughly three-quarters of cats with chronic enteropathy show an altered profile by that measure.

    Do FOS and MOS do the same thing?
    No, and this is a common oversimplification. FOS is fermentable — beneficial bacteria consume it, producing short-chain fatty acids and lowering gut pH. MOS is only partially fermented; its main documented role is binding the mannose-specific fimbriae that some pathogens use to attach to the gut wall, so they pass through instead of colonizing. Both support the gut environment, by different routes.

    Next in the Feline Gut Health Series

    We've covered what the feline gut microbiome is and what disrupts it, the effect of antibiotics on it, what probiotics do and don't do for diarrhea, and now the gut–immune connection. If you want to be able to read a probiotic label properly — and tell a meaningful one from a vague one — start with Cat Probiotics: Strain IDs, CFU, and What Matters.

    Sources
    Gallagher A. The Digestive System in Animals. Merck Veterinary Manual. Full review Jul 2025; last updated Apr 2026. https://www.merckvetmanual.com/digestive-system/digestive-system-introduction/the-digestive-system-in-animals — gut-associated lymphoid tissue (tonsils, Peyer's patches, diffuse lymphoid tissue) is distributed along the GI tract.
    Bemark M, Pitcher MJ, Dionisi C, Spencer J. Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity. Trends in Immunology. 2024. PMID:38402045 — Peyer's patch structure, antigen sampling, and IgA class switching; the microbiota maintains GALT in a chronically activated state.
    Sung CH, Marsilio S, Chow B, et al. Dysbiosis index to evaluate the fecal microbiota in healthy cats and cats with chronic enteropathies. Journal of Feline Medicine and Surgery. 2022. doi:10.1177/1098612X221077876 — approximately 76% of cats with chronic enteropathy have an altered fecal microbiota; patterns resemble human IBD.
    Characterization of the fecal microbiome in cats with inflammatory bowel disease or alimentary small cell lymphoma. PMC6914782 — reduced alpha diversity and shifts in Firmicutes, Actinobacteria, and Enterobacteriaceae in affected cats.
    Chronic Inflammatory Enteropathy and Low-Grade Intestinal T-Cell Lymphoma Are Associated with Altered Microbial Tryptophan Catabolism in Cats. PMC10777963 — microbial metabolite signaling differs in cats with intestinal disease.
    Amaral AR, Risolia LW, et al. Translating Human and Animal Model Studies to Dogs' and Cats' Veterinary Care: Beta-Glucans Application for Skin Disease, Osteoarthritis, and Inflammatory Bowel Disease Management. Microorganisms. 25 May 2024. PMC11205328 — beta-glucan recognition pathways (Dectin-1, CR3) and the current state of companion-animal evidence.
    The Influence of β-1,3-1,6-Glucans on Rabies Vaccination Titers in Cats. Veterinary Sciences. 2020;7(3):118. doi:10.3390/vetsci7030118 — 35 cats, RFFIT titers at days 0, 21, 42; the non-supplemented group had higher post-vaccination titers.
    Veir JK, Knorr R, Cavadini C, et al. Effect of supplementation with Enterococcus faecium (SF68) on immune functions in cats. Veterinary Therapeutics. 2007;8(4):229–238. PMID:18183541 — total fecal IgA and IgG concentrations were similar between groups; the significant finding was CD4+ lymphocyte percentage.
    Benyacoub J, Czarnecki-Maulden GL, Cavadini C, et al. Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs. Journal of Nutrition. 2003;133(4):1158–1162 — the fecal IgA increase associated with SF68 was demonstrated in puppies, not cats.
    Impact of Saccharomyces cerevisiae DSM 34246 (Canobios-BL) var. boulardii Supplementation on Nutritional Status and Fecal Parameters in Healthy Breeding Adult Cats. Veterinary Sciences. 2025;12(1):44. PMC11769004 — randomized blinded controlled trial, 35 days; significant increase in fecal IgA in healthy adult cats. Strain differs from the S. boulardii in ResiliBiome.
    Postbiotic supplementation promotes gut barrier integrity and immune balance in cats via microbiota modulation. Frontiers in Microbiology. 2025. doi:10.3389/fmicb.2025.1692845 — 18 healthy cats, 28 days, heat-inactivated Bifidobacterium animalis subsp. lactis; reduced permeability markers and altered immune signaling. Organism differs from the fermentate in ResiliBiome.
    Kim et al. Feline-origin Lactobacillus rhamnosus CACC612 and Bifidobacterium animalis subsp. lactis CACC789. BMC Veterinary Research. 2024. PMC10983674 — feline-origin isolates showed superior bile tolerance versus a human-derived reference strain, with comparable adhesion.
    From conventional probiotics to precision nutrition: host-specific probiotics in canine and feline functional foods. Frontiers in Veterinary Science. 2026. doi:10.3389/fvets.2026.1881134 — rationale for host-specific probiotic strain selection.
    Kanakupt K, et al. Short-chain fructooligosaccharides and galactooligosaccharides in healthy adult cats. Journal of Animal Science. 2011;89(5):1376. doi:10.2527/jas.2010-3201 — scFOS increased Bifidobacterium spp., increased butyrate and valerate, and lowered fecal pH in cats.
    Barry KA, et al. Dietary cellulose, fructooligosaccharides, and pectin modify fecal protein catabolites and microbial populations in adult cats. Journal of Animal Science. 2010;88(9):2978 — FOS fermentation effects in adult cats.
    Review of mannan oligosaccharide trials in farm and companion animals. World's Poultry Science Journal. 73(4). doi:10.1017/S0043933917000757 — MOS binds mannose-specific type-1 fimbriae on enteropathogens, reducing adhesion; supports mucin and goblet cell activity.
    Frontiers in Microbiology. 2025;16:1529081. PMC11973258 — MOS is only partially fermentable; its primary mechanism is interference with pathogen adhesion rather than acting as a fermentation substrate.

    This article is general education and is not veterinary advice. It is not intended to diagnose, treat, cure or prevent any disease. Talk to your veterinarian about your individual cat.

    Leave a comment